Navigation Links
Pacira Pharmaceuticals, Inc. Reports First Quarter 2011 Financial Results
Date:5/11/2011

b>Full Year 2011 Financial GuidancePacira is reiterating its 2011 financial guidance and currently expects to achieve revenue in the range of $14 and $16 million for the full-year ending December 31, 2011.  This revenue expectation excludes the impact of potential sales of EXPAREL should it receive approval from the FDA in the third quarter of 2011 and be commercialized by Pacira in the fourth quarter of 2011.  The company also expects cash burn, excluding the impact of any future partnerships, asset monetizations or other cash generating activities unrelated to its current operations, to be approximately $30 million cumulatively through the third quarter of 2011, and, approximately $25 million in the fourth quarter of 2011.  These cash burn expectations are based upon the assumption that EXPAREL will receive FDA approval in the third quarter of 2011, and that Pacira will commercialize EXPAREL in the fourth quarter of 2011, and include a $10 million milestone payment in the fourth quarter of 2011 to Skye Pharmaceuticals due upon the first commercial sale of EXPAREL.  

Recent Developments

  • Entered into a Partner Program Agreement with Novo Nordisk:  In January 2011 Pacira entered into an agreement with Novo Nordisk A/S (Novo), pursuant to which Pacira granted Novo Nordisk rights to develop, manufacture and commercialize formulations of a Novo Nordisk proprietary drug using Pacira's DepoFoam® drug delivery technology. Pacira received an upfront license fee of $1.5 million and is entitled to receive up to $24 million in development-based milestone payments and up to an additional $20 million in sales-based milestone payments. Pacira is also entitled to single-digit royalties on sales of any Novo Nordisk product resulting from this development agreement.
  • Presented new Phase 3 EXPAREL data at two medical meetings: In January 2011 data from Pacira's Phase 3 multicenter, randomized, double-bli
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations
    2. Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2011 Financial Results Webcast and Conference Call
    3. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    4. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
    5. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    6. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    8. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    9. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    10. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    11. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/24/2015)... 2015 Today, humanity takes a massive step toward ... fat-free cronuts: 1-800 CONTACTS announces their new Apple Watch app ... taps. Two taps. New contacts. From your watch. ... app also features LensGauge which helps keep track of how ... to reorder. "Since our inception, we,ve been dedicated ...
    (Date:4/24/2015)... Allowing more basic emergency medical service (EMS) staff to ... opioids, according to a Centers for Disease Control and ... Medical Service Providers and the Burden of Drug Overdose ... of Public Health . In 2013, more ... involved prescription opioids, and more than 8,000 ...
    (Date:4/24/2015)... 24, 2015  IGI Laboratories, Inc. (NYSE MKT: IG), ... generic pharmaceutical company, announced the Company will hold a ... 28, 2015 to discuss the 1st quarter 2015 results. ... the call by dialing 1-888-346-3479. International participants should call ... to be joined into the IGI Laboratories, Inc. call. ...
    Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Expanding Naloxone use could reduce drug overdose deaths and save lives 2Expanding Naloxone use could reduce drug overdose deaths and save lives 3
    ... Zimmer Holdings, Inc. (NYSE and SIX: ... $550 million of senior notes in an underwritten public offering ... Paribas Securities Corp. and RBS Securities Inc., as joint ... Securities (USA) LLC, Citigroup Global Markets Inc., Mitsubishi UFJ ...
    ... -- Mindray Medical International Limited ("Mindray" or "Company", NYSE: ... marketer of medical devices worldwide, today announced that its ... The share repurchase program is authorized to be in ... Mindray is authorized to repurchase up to US$100 million ...
    Cached Medicine Technology:Zimmer Holdings, Inc. Agrees to Sell $550 Million of Senior Notes 2Mindray Announces Up to $100 Million Share Repurchase Program 2Mindray Announces Up to $100 Million Share Repurchase Program 3
    (Date:4/27/2015)... New York, NY (PRWEB) April 27, 2015 ... par8o are creating a seamless referral process for the ... patients with chronic heart failure or diabetes, for instance, ... and most primary physicians coordinate with many other care ... System referring hundreds of thousands of patients each year, ...
    (Date:4/27/2015)... CA (PRWEB) April 27, 2015 Healthpointe ... invasive treatments for nail fungi and infections. Onychomycosis, which ... affect up to 10% of adults in the Western ... and irregularity in thickness. , Healthpointe’s Anaheim ... , a branch dedicated to providing quality skincare products ...
    (Date:4/27/2015)... Dallas, Texas (PRWEB) April 27, 2015 ... expected to grow at a CAGR of 5.9% during ... greatest market share in the materials healthcare packaging market, ... The Global Pharmaceutical Packaging market is extremely ... companies occupy a major portion of the market with ...
    (Date:4/27/2015)... Texas has saved $433 million by converting ... providing drug offenders with addiction treatment, according to an ... Several states, including Massachusetts, are considering adopting justice reinvestment ... formed community recovery programs to help redress rampant addiction ... State Governments WA, ID, NE, KS, MI, PA, ...
    (Date:4/27/2015)... April 27, 2015 Los Angeles ... offering comprehensive gummy smile treatments. “Some people have too ... explains, “It is a purely cosmetic issue that can ... unnecessary tissues and expose more of the natural tooth ... be used to reshape the underlying bone and create ...
    Breaking Medicine News(10 mins):Health News:Mount Sinai Launches System for Faster Referrals 2Health News:Mount Sinai Launches System for Faster Referrals 3Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Los Angeles Periodontist, Dr. Sharyar Baradaran, Now Offers Comprehensive Treatments to Correct Gummy Smiles 2
    ... MAYWOOD, Ill. -- Dr. Edward Duckworth is part of ... surgery a lot easier on patients. , At Loyola ... tumors, to repair life-threatening aneurysms and to dramatically reduce ... sections of the skull or face, Duckworth is reaching ...
    ... calories, hints of new ways to treat obesity , , ... bone growth also helps promote development of "good" brown fat ... obesity, says researchers at the Joslin Diabetes Center in Boston. ... may help lead to new ways to prevent and treat ...
    ... Agenda to Launch Summit Conversations Series, WASHINGTON, ... will be honoring Rep. Richard "Dick" Gephardt, former ... to affordable,health care for every American at the ... spirit of "health care for all Americans,",America,s Agenda ...
    ... designed to,monitor and care for the elderly population ... billion by 2013., Technological advances will drive ... Parks Associates, Taking Care of the Elderly through,Digital ... measurement devices will bring in more than twice ...
    ... introduce new light beer, ... Stampede Light Plus(R), DALLAS, ... Everyone knows about Jessica Simpson,s daisy dukes body and healthy,lifestyle. The ... making healthy food choices. But she also makes,those smart choices with ...
    ... Aug. 20 Cord Blood America, Inc.,(OTC Bulletin ... preservation,company ( http://www.cordblood-america.com ) focused on bringing the ... and internationally,today reported that revenues for the first ... million., Revenues were down from the same ...
    Cached Medicine News:Health News:Brain surgery is getting easier on patients 2Health News:Brain surgery is getting easier on patients 3Health News:Bone Growth Protein Also Promotes 'Good' Fat 2Health News:America's Agenda to Honor Former House Majority Leader Richard Gephardt at Democratic National Convention 2Health News:Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013 2Health News:Jessica Simpson Lends Healthy Image for Drink Smart Campaign 2Health News:Jessica Simpson Lends Healthy Image for Drink Smart Campaign 3Health News:Cord Blood America Reports Six Month Financial Results 2
    ... system capable of handling a multitude of ... of the tests allows you to tailor ... staffs' needs. Any tests not included in ... easily be handled using the Doppler, PVR ...
    ... Nicolet VersaLab is a ... Doppler system for evaluation ... Crisp, clear Doppler sound ... a display and print-out ...
    Silhouette is easy to use with uncompromised biomechanics and is the most refined posterior fixation system....
    The CD Horizon Legacy Spinal System is part of the CD Horizon Spinal System designed for use in small stature patients. The posterior implants (hook and screws) are designed to fit patients in the ra...
    Medicine Products: